Search

Your search keyword '"Lundvall, L"' showing total 242 results

Search Constraints

Start Over You searched for: Author "Lundvall, L" Remove constraint Author: "Lundvall, L"
242 results on '"Lundvall, L"'

Search Results

2. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk

3. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

6. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

10. Dysregulation of FGFR signalling by a selective inhibitor reduces germ cell survival in human fetal gonads of both sexes and alters the somatic niche in fetal testes

11. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

12. Dysregulation of FGFR signalling by a selective inhibitor reduces germ cell survival in human fetal gonads of both sexes and alters the somatic niche in fetal testes

13. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

14. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

15. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

16. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

17. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival

18. Risk of Ovarian Cancer and the NF-? B Pathway: Genetic Association with IL1A and TNFSF10

19. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

20. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration

21. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

22. Dysregulation of FGFR signalling by a selective inhibitor reduces germ cell survival in human fetal gonads of both sexes and alters the somatic niche in fetal testes.

23. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study

24. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

25. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

26. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

27. Adult body mass index and risk of ovarian cancer by subtype: A Mendelian randomization study

28. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

29. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

30. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

31. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer

32. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

33. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

34. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

35. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

36. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

37. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

38. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk

39. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

40. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

41. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

42. Genome-wide significant risk associations for mucinous ovarian carcinoma

43. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

44. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk

46. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk

47. Risk of ovarian cancer and the NF-kappaB pathway: genetic association with IL1A and TNFSF10

48. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

49. The Crystal Structure of Lipopolysaccharide Binding Protein Reveals the Location of a Frequent Mutation that Impairs Innate Immunity

50. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Catalog

Books, media, physical & digital resources